By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Raptor Pharmaceutical Inc. 

7 Hamilton Landing
Suite 100
Novato  California  94949  U.S.A.
Phone: 415-408-6200 Fax: 415-382-8002


Key Statistics

Ownership: Public

Web Site: Raptor
Symbol: RPTP



Company News
BioMarin (BMRN), Raptor (RPTP), Buck Institute for Age Research Lead Marin Biotech Boom 12/31/2015 1:37:17 PM
Raptor (RPTP) Plans To Advance RP103 In A Registration Study In Huntington's Disease Based On Favorable Treatment Effects At 36 Months In CYST-HD Trial 12/10/2015 7:51:27 AM
Raptor (RPTP) Release: NIDDK Provides Additional Data From Cynch Study Evaluating RP103 In Pediatric NASH At American Association for Study of Liver Diseases 11/16/2015 7:48:15 AM
Raptor (RPTP) To Hold Third Quarter 2015 Financial Results Conference Call And Webcast On Thursday, November 5, 2015, At 4:30 P.M. ET 10/30/2015 8:07:22 AM
Raptor (RPTP) Completes Acquisition of Quinsair 10/5/2015 7:20:27 AM
Raptor (RPTP) To Participate In The Leerink Partners 4th Annual Rare Disease Roundtable 9/23/2015 8:48:29 AM
Raptor (RPTP)'s Phase IIb CyNCh Study Fails To Meet Primary Endpoint, Shares Skid 9/14/2015 6:03:51 AM
Bay Area's Raptor (RPTP) Beefs Up Portfolio With $453 Million Deal for Quinsair 8/21/2015 6:05:30 AM
Raptor Pharmaceutical Inc. (RPTP) Voted A "Best Places To Work" Company In The North San Francisco Bay Area 8/20/2015 8:16:08 AM
Raptor Pharmaceutical Inc. (RPTP) Receives FDA Approval Of Expanded Label For PROCYSBI To Treat Children Aged 2-6 Years With Nephropathic Cystinosis 8/17/2015 6:02:11 AM